The DOI matches its Crossref record; 124 of the 124 references it cites were found in a registry or an index.
Biomarkers for epithelial-mesenchymal transitions
Open accessAbstract
Somatic cells that change from one mature phenotype to another exhibit the property of plasticity. It is increasingly clear that epithelial and endothelial cells enjoy some of this plasticity, which is easily demonstrated by studying the process of epithelial-mesenchymal transition (EMT). Published reports from the literature typically rely on ad hoc criteria for determining EMT events; consequently, there is some uncertainty as to whether the same process occurs under different experimental conditions. As we discuss in this Personal Perspective, we believe that context and various changes in plasticity biomarkers can help identify at least three types of EMT and that using a collection of criteria for EMT increases the likelihood that everyone is studying the same phenomenon - namely, the transition of epithelial and endothelial cells to a motile phenotype.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Moreover, proteins in the most significantly up-regulated network module (Extended Data Fig. 10d, 10f) included collagens (COL1A1 and COL3A1) and extracellular matrix glycoproteins (FN1, BGN, FBN1, and FBN2) that also are markers of EMT34, 35.”
From Proteogenomic characterization of human colon and rectal cancer (2014) · cites this paper as [35]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The basics of epithelial-mesenchymal transition
Kalluri, R., & Weinberg, R. A. (2009) · Journal of Clinical Investigation · doi:10.1172/jci39104 · Cited by 10,196
The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells
Mani, S. A., Guo, W., Liao, M.-J., Eaton, E. N., Ayyanan, A., Zhou, A. Y., Brooks, M. W., Reinhard, F., Zhang, C. C., Shipitsin, M. V., et al. (2008) · Cell · doi:10.1016/j.cell.2008.03.027 · Cited by 8,839
Kalluri, R., & Zeisberg, M. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1877 · Cited by 4,538
Self-citationTumors: Wounds That Do Not Heal
Flier, J. S., Underhill, L. H., & Dvorak, H. F. (1986) · New England Journal of Medicine · doi:10.1056/nejm198612253152606 · Cited by 4,391
Complex networks orchestrate epithelial–mesenchymal transitions
Thiery, J. P., & Sleeman, J. P. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1835 · Cited by 3,947
Twist, a Master Regulator of Morphogenesis, Plays an Essential Role in Tumor Metastasis
Yang, J., Mani, S. A., Donaher, J. L., Ramaswamy, S., Itzykson, R., Côme, C., Savagner, P., Gitelman, I., Richardson, A. L., & Weinberg, R. A. (2004) · Cell · doi:10.1016/j.cell.2004.06.006 · Cited by 3,917
Gregory, P. A., Bert, A. G., Paterson, E. L., Barry, S. C., Tsykin, A., Farshid, G., Vadas, M. A., Khew‐Goodall, Y., & Goodall, G. J. (2008) · Nature Cell Biology · doi:10.1038/ncb1722 · Cited by 3,852
Epithelial-Mesenchymal Transition: At the Crossroads of Development and Tumor Metastasis
Yang, J., & Weinberg, R. A. (2008) · Developmental Cell · doi:10.1016/j.devcel.2008.05.009 · Cited by 3,079
Epithelial-mesenchymal transition and its implications for fibrosis
Kalluri, R., & Neilson, E. G. (2003) · Journal of Clinical Investigation · doi:10.1172/jci20530 · Cited by 2,715
Self-citationTumour invasion and metastasis initiated by microRNA-10b in breast cancer
Ma, L., Teruya-Feldstein, J., & Weinberg, R. A. (2007) · Nature · doi:10.1038/nature06174 · Cited by 2,605
Flagged first, then by citations
Research works printed but not linked: 8
- Kalluri, 2003, J. Clin. Invest., 112, 1776, 10.1172/JCI200320530 · DOI
- Xue, 2003, Cancer Res., 63, 3386
- Colwell, 2005, Adv. Biochem. Eng. Biotechnol., 93, 83
- Sommers, 1989, Cancer Res., 49, 4258
- Wernert, 2001, Anticancer Res., 21, 2259
- Higgins, 2007, J. Clin. Invest., 117, 3810
- Bates, 2005, J. Clin. Invest., 115, 339, 10.1172/JCI200523183 · DOI
- Gabbiani, 1981, Am. J. Pathol., 104, 206
Cited by
Sorted by citations
Items 601–700 of 1,004
Wu, S., Luo, Z., Yu, P. Y., Xie, H., & He, Y. (2015) · Biological Chemistry · doi:10.1515/hsz-2015-0215 · Cited by 53
miR-26a-5p suppresses tumor metastasis by regulating EMT and is associated with prognosis in HCC
Chang, L., Li, K., & Guo, T. (2016) · Clinical & Translational Oncology · doi:10.1007/s12094-016-1582-1 · Cited by 52
The inhibition of lung cancer cell migration by AhR-regulated autophagy
Tsai, C.-H., Li, C.-H., Cheng, Y., Lee, C., Liao, P.-L., Lin, C., Huang, S.-H., & Kang, J. (2017) · Scientific Reports · doi:10.1038/srep41927 · Cited by 50
“These changes in cell morphology and function are accompanied by vimentin and snail protein expression 14,15 .”
Xu, S., Zhan, M., & Wang, J. (2017) · Cell Death Discovery · doi:10.1038/cddiscovery.2017.69 · Cited by 52
Deng, R., Zhang, J., & Chen, J.-T. (2018) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2018.4039 · Cited by 53
“Type 3 EMT occurs in epithelial carcinoma cells, generating secondary tumor nodules by transforming these cells to metastatic tumor cells that migrate to metastatic sites (40).”
BackgroundInsights on CTC Biology and Clinical Impact Emerging from Advances in Capture Technology
Bailey, P. C., & Martin, S. S. (2019) · Cells · doi:10.3390/cells8060553 · Cited by 53
“There can be as many as six different clonal cell lines within just one tumor [123].”
BackgroundLi, J., Yang, R., Dong, Y., Chen, M., Wang, Y., & Wang, G. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1046-x · Cited by 50
RetractedMesenchymal Stem Cells in the Adult Human Liver: Hype or Hope?
Kholodenko, I. V., Kurbatov, L. K., Kholodenko, R. V., Manukyan, G. V., & Yarygin, K. N. (2019) · Cells · doi:10.3390/cells8101127 · Cited by 54
“Importantly, both cadherins (-2 and -11) are involved in the epithelial-to-mesenchymal transition [70].”
BackgroundTargeted genomic CRISPR-Cas9 screen identifies MAP4K4 as essential for glioblastoma invasion
Prolo, L. M., Li, A., Owen, S. F., Parker, J. J., Foshay, K. M., Nitta, R. T., Morgens, D. W., Bolin, S., Wilson, C., Leonel, J. C. M. V., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-50160-w · Cited by 50
Shen, K., Hung, J., Liao, Y.-C., Tsai, S., Wu, M., & Chen, P.-S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21093080 · Cited by 53
“The process of EMT is associated with the downregulation of epithelial markers such as E-cadherin, and the upregulation of mesenchymal markers such as vimentin [15].”
BackgroundChemical Factory‐Guaranteed Enhanced Chemodynamic Therapy for Orthotopic Liver Cancer
Tang, Z., Wu, S., Zhao, P., Wang, H., Ni, D., Li, H., Jiang, X., Wu, Y., Meng, Y. F., Yao, Z., et al. (2022) · Advanced Science · doi:10.1002/advs.202201232 · Cited by 51
Ji, X., Li, J., Xu, L., Wang, W., Luo, M., Luo, S., Ma, L., Li, K., Gong, S., He, L., et al. (2013) · Europe PMC (PubMed Central) · Cited by 51
Mutant p53 expression in fallopian tube epithelium drives cell migration
Quartuccio, S. M., Karthikeyan, S., Eddie, S. L., Lantvit, D. D., hAinmhire, E. Ó., Modi, D., Wei, J., & Burdette, J. E. (2015) · International Journal of Cancer · doi:10.1002/ijc.29528 · Cited by 51
Role of fucosyltransferase IV in epithelial–mesenchymal transition in breast cancer cells
Yang, X., Liu, S., & Yan, Q. (2013) · Cell Death and Disease · doi:10.1038/cddis.2013.241 · Cited by 53
“recognized as a hallmark of embryogenesis in the early 1980.(1,2) EMT is also a key event in the tumor-invasion process and has been implicated in increased cell invasion”
BackgroundLIN, Z.-H., Wang, L., Zhang, J., Liu, Y., Li, X., Guo, L., ZHANG, B., Zhu, W., & Ye, Q. (2014) · International Journal of Oncology · doi:10.3892/ijo.2014.2455 · Cited by 49
You, S., Avidan, O., Tariq, A., Ahluwalia, I. P., Stark, P. C., Kublin, C. L., & Zoukhri, D. (2011) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.11-7893 · Cited by 49
“Snai1 appears to be the master regulator of EMT, although several other factors such as Snai2 (SLUG), ZEB1 ( EF1), ZEB2 (SIP1), and TWIST are also known to induce or contribute to EMT.1,2,4,5 Repression of Snai1 expression is usually sufficient to induce E-cadherin expression and the cells acquire an epithelial phenot…”
BackgroundInfluentialFunctional Cooperation of RKTG with p53 in Tumorigenesis and Epithelial–Mesenchymal Transition
Jiang, Y., Xie, X., Li, Z., Wang, Z., Zhang, Y., Ling, Z., Pan, Y., Wang, Z., & Chen, Y. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-4077 · Cited by 51
“This process involves the acquisition of mesenchymal markers, such as vimentin and fibronectin, together with loss of epithelial cell adhesion molecules such as E-cadherin (16).”
Hyperinsulinemia promotes metastasis to the lung in a mouse model of Her2-mediated breast cancer
Ferguson, R. D., Gallagher, E. J., Cohen, D., Tobin‐Hess, A., Alikhani, N., Novosyadlyy, R., Haddad, N., Yakar, S., & LeRoith, D. (2013) · Endocrine Related Cancer · doi:10.1530/erc-12-0333 · Cited by 51
“Vimentin belongs to the intermediate filament (IF) family of proteins and has recently been shown to be an important marker of the EMT in epithelial cells that normally express only cytokeratin-type IFs (Zeisberg & Neilson 2009, Satelli & Li 2011).”
BackgroundActivation of pancreatic stellate cells involves an EMT-like process
TIAN, L., Lu, Z., Cai, B., Zhao, L., QIAN, D., Xu, Q., Wu, P., Zhu, Y., Zhang, J., Du, Q., et al. (2015) · International Journal of Oncology · doi:10.3892/ijo.2015.3282 · Cited by 51
“Type 2 EMT is characterized by conversion from endothelial or epithelial cells into fibroblasts, which are responsible for tissue inflammation and fibrosis, such as that seen in PDAC (27,28).”
BackgroundInfluentialZhang, N., Liu, Y., Wang, Y., Zhao, M., Tu, L., & Luo, F. (2017) · Drug Design Development and Therapy · doi:10.2147/dddt.s129305 · Cited by 51
Cancer Stem Cells and Metastasis
Nandy, S., & Lakshmanaswamy, R. (2017) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2017.07.007 · Cited by 50
Yang, Y., Sun, Y., Wu, Y., Tang, D., Ding, X., Xu, W., Su, B., & Gao, W. (2018) · Molecular Carcinogenesis · doi:10.1002/mc.22805 · Cited by 51
“During EMT, cells are characterized by decreased expression of the epithelial marker E-cadherin and increased expressions of the mesenchymal markers N-cadherin and Vimentin.(7) Cancer cells that acquire stromal”
BackgroundInfluentialMiao, H., Zhang, Y., Huang, Z., Lü, B., & Ji, L. (2019) · The American Journal of Chinese Medicine · doi:10.1142/s0192415x19500174 · Cited by 51
Zhang, Q., Huang, F., Yao, Y., Wang, J., Wei, J., Wu, Q., Xiang, S., & Xu, L. (2019) · Cancer Science · doi:10.1111/cas.14101 · Cited by 52
Ding, Y., Hao, K., Li, Z., Ma, R., Zhou, Y. L., Zhou, Z., Wei, M., Liao, Y., Dai, Y., Yang, Y., et al. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.29317 · Cited by 52
“…of epithelial cells to motile mesenchymal cells is a process known as epithelial–mesenchymal transition (EMT), and there are now many biomarkers, including cell surface proteins, cytoskeletal markers, and transcription factors for EMT (Feng, Zhao, Lu, Wang, & Chen, 2017; Zeisberg & Neilson, 2009).”
BackgroundAdaptation and selection shape clonal evolution of tumors during residual disease and recurrence
Walens, A., Lin, J., Damrauer, J. S., McKinney, B. J., Lupo, R., Newcomb, R., Fox, D. B., Mabe, N. W., Gresham, J. S., Sheng, Z., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-18730-z · Cited by 52
Yamben, I. F., Rachel, R. A., Shatadal, S., Copeland, N. G., Jenkins, N. A., Warming, S., & Griep, A. E. (2013) · Developmental Biology · doi:10.1016/j.ydbio.2013.09.027 · Cited by 50
“The Apical Marker, ZO-1, is Gradually Lost From Epithelial Cells of the ScribLeCre Lenses Another hallmark of EMT is the loss of the apically-restricted tight junction protein, ZO-1 (Zeisberg and Neilson, 2009).”
BackgroundChen, Y., Chuang, T.-Y., Liu, C., Liu, C.-W., Lai, T.-C., Lai, T.-C., & Chen, Y. (2020) · Particle and Fibre Toxicology · doi:10.1186/s12989-020-00373-z · Cited by 52
ESRRA promotes gastric cancer development by regulating the CDC25C/CDK1/CyclinB1 pathway via DSN1
Li, F.-N., Zhang, Q., Li, O., Liu, S., Yang, Z., Pan, L., Zhao, C., Gong, W., Shu, Y., & Dong, P. (2021) · International Journal of Biological Sciences · doi:10.7150/ijbs.57623 · Cited by 50
“Especially, E-cadherin to N-cadherin switch in cancer cells relates to cancer progression[10].”
BackgroundZhang, Q., Wang, Z., Cheng, X., & Wu, H. (2021) · Bioengineered · doi:10.1080/21655979.2021.1988373 · Cited by 50
“EMT is necessary for cell migration and invasion, and it is characterized by the low-expressed key epithelial markers (E-cadherin) and high-expressed mesenchymal markers (β-catenin and vimentin) [32,33], among which the E-cadherin expression is negatively connected with the cell EMT, while both Vimentin and N-cadherin…”
BackgroundWang, D., Han, S., Wang, X., Peng, R., & Li, X. (2015) · Medical Oncology · doi:10.1007/s12032-014-0461-2 · Cited by 50
Hu, J., Yang, D., Zhang, H., Liu, W., Zhao, Y., Lu, H., Meng, Q., Pang, H., Chen, X., Liu, Y., et al. (2015) · Lung Cancer · doi:10.1016/j.lungcan.2015.02.019 · Cited by 50
Hong, F., Hong, J., Wang, L., Zhou, Y., Liu, D., Xu, B., Yu, X., & Sheng, L. (2015) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf5034834 · Cited by 50
Loeffler, I., Liebisch, M., Allert, S., Kunisch, E., Kinne, R. W., & Wolf, G. (2017) · Cell and Tissue Research · doi:10.1007/s00441-017-2754-1 · Cited by 51
“**P = 0.01 is expressed in themouse from embryonic day 8.5 and is associated with cells of mesenchymal origin or of fibroblastic phenotype (Luo et al. 2015; Strutz et al. 1995; Zeisberg and Neilson 2009).”
InfluentialLiu, M., Liu, L., Bai, M., Zhang, L., Ma, F., Yang, X., & Sun, S. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.12.130 · Cited by 50
Dong, Y., Wu, Z., He, M., Chen, Y., Chen, Y., Shen, X., Zhao, X., Zhang, L., Yuan, B., & Zeng, Z. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.02.010 · Cited by 51
Deregulating MYC in a model of HER2+ breast cancer mimics human intertumoral heterogeneity
Risom, T., Wang, X., Liang, J. B., Zhang, X., Pelz, C., Campbell, L. G., Eng, J., Chin, K., Farrington, C. C., Narla, G., et al. (2019) · Journal of Clinical Investigation · doi:10.1172/jci126390 · Cited by 48
Wang, X., Zhang, W., Sun, X., Lin, Y., & Chen, W. (2018) · Oncology Letters · doi:10.3892/ol.2018.8000 · Cited by 52
“There is increasing evidence indicating that EMT is stimulated by signals from the tumor microenvironment, including a variety of growth factors and cytokines (8,9).”
InfluentialTreloar, K. K., Simpson, M. J., Haridas, P., Manton, K. J., Leavesley, D. I., McElwain, D. L. S., & Baker, R. E. (2013) · BMC Systems Biology · doi:10.1186/1752-0509-7-137 · Cited by 51
“To confirm the presence of cell motility and cell–to–cell adhesion proteins in the cell colony, we used immunofluorescence to examine the expression of E–cadherin, N–cadherin and vimentin [3,47,52,53].”
MethodWang, W., Cheng, J., Qin, J., Voruganti, S., Nag, S. A., Fan, J., Gao, Q., & Zhang, R. (2014) · Oncotarget · doi:10.18632/oncotarget.2598 · Cited by 49
Gottschling, S., Granzow, M., Kuner, R., Jauch, A. S., Herpel, E., Xu, E. C., Muley, T., Schnabel, P. A., Herth, F. J. F., & Meister, M. A. (2013) · Lung Cancer · doi:10.1016/j.lungcan.2012.12.015 · Cited by 53
Muir, A. B., Dods, K. K., Noah, Y., Toltzis, S., Chandramouleeswaran, P. M., Lee, A., Benitez, A., Bedenbaugh, A., Falk, G. W., Wells, R. G., et al. (2014) · Experimental Cell Research · doi:10.1016/j.yexcr.2014.08.026 · Cited by 49
“marker analysis alone, and must demonstrate acquisition of functional characteristics of activated myofibroblasts, including migration, contraction, and collagen deposition [8,21].”
BackgroundNguyen, T. L. L., Grizzle, W. E., Zhang, K., Hameed, O., Siegal, G. P., & Wei, S. (2013) · American Journal of Clinical Pathology · doi:10.1309/ajcpz1d8calhdxcj · Cited by 49
Qu, X., Shen, L., Zheng, Y., Cui, Y., Liu, F., Liu, J., & Liu, J. (2013) · Journal of Investigative Dermatology · doi:10.1038/jid.2013.281 · Cited by 49
Venza, M., Visalli, M., Catalano, T., Biondo, C., Beninati, C., Teti, D. V., & Venza, I. (2016) · Oncology Reports · doi:10.3892/or.2016.4618 · Cited by 49
Hu, Y., Mou, L., Yang, F., Tu, H., & Lin, W. (2016) · Molecular Medicine Reports · doi:10.3892/mmr.2016.5601 · Cited by 49
Ding, Y., Pan, Y., Liu, S., Jiang, F., & Jiao, J. (2017) · Cancer Biology & Therapy · doi:10.1080/15384047.2017.1323585 · Cited by 49
Sun, D., Shen, W., Zhang, F., Fan, H., Xu, C., Li, L., Tan, J., Miao, Y., Zhang, H., Yang, Y., et al. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.02.062 · Cited by 49
Molecular targets and pathways involved in liver metastasis of colorectal cancer
Weidle, U. H., Birzele, F., & Krüger, A. (2015) · Clinical & Experimental Metastasis · doi:10.1007/s10585-015-9732-3 · Cited by 51
Zhou, D., Tang, W., Zhang, Y., & An, H. (2019) · Cancer Management and Research · doi:10.2147/cmar.s189937 · Cited by 48
“EMT, which is known as the first step required for the complex process of metastasis, is critical for polarized epithelial cells to obtain enhanced invasion and migration abilities.(29,30) EMT is often observed in primary tumor at the cancer invasion front.”
BackgroundInsight into the role of DPP-4 in fibrotic wound healing
Zhang, K., Liu, S., Jia, Y., Zou, M., Teng, Y., Chen, Z.-H., Li, Y., Guo, D., Wu, J., Yuan, Z., et al. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113143 · Cited by 50
Gołąbek-Grenda, A., & Olejnik, A. M. (2022) · Cellular Signalling · doi:10.1016/j.cellsig.2022.110375 · Cited by 53
Weng, Y., Wang, H., Wu, D., Xu, S., Chen, X., Huang, J., Feng, Y., Li, L., & Wang, Z. (2022) · Cell Research · doi:10.1038/s41422-022-00687-x · Cited by 52
Epithelial-mesenchymal transitions in bronchopulmonary dysplasia of newborn rats
Yang, H., Fu, J., Xue, X., Li, Y., Lin, Q., Hou, A., Jin, L., & Xing, Y. (2014) · Pediatric Pulmonology · doi:10.1002/ppul.22969 · Cited by 48
“SPC and E-cadherin are epithelial cell markers, while a-SMA and N-CAD are mesenchymal cell markers.(34) Using immunoblot analysis, we found that on Days 14 and 21, the protein and mRNA expression levels of SPC in the lung tissues from BPD model group were significantly higher than those in the control group, indicatin…”
BackgroundNanobiotechnology for the capture and manipulation of circulating tumor cells
Hughes, A. D., & King, M. R. (2011) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.168 · Cited by 48
Low-dose radiation-induced epithelial-mesenchymal transition through NF-κB in cervical cancer cells
YAN, S., Wang, Y., Yang, Q., Li, X., Kong, X., Zhang, N., Yuan, C., Yang, N., & Kong, B. (2013) · International Journal of Oncology · doi:10.3892/ijo.2013.1852 · Cited by 48
Androgen regulation of epithelial–mesenchymal transition in prostate tumorigenesis
Matuszak, E. A., & Kyprianou, N. (2011) · Expert Review of Endocrinology & Metabolism · doi:10.1586/eem.11.32 · Cited by 48
Samudio‐Ruiz, S. L., & Hudson, L. G. (2012) · Epigenetics · doi:10.4161/epi.7.3.19273 · Cited by 48
Burdick, M. M., Henson, K. A., Delgadillo, L. F., Choi, Y. E., Goetz, D. J., Tees, D. F. J., & Benencia, F. (2012) · Frontiers in Oncology · doi:10.3389/fonc.2012.00103 · Cited by 49
Naz, S., Bashir, M., Ranganathan, P., Bodapati, P., Santosh, V., & Kondaiah, P. (2013) · Carcinogenesis · doi:10.1093/carcin/bgt287 · Cited by 48
Fu, J., KE, X., Tan, S., Liu, T., Wang, S., Ma, J., & Lu, H. (2015) · Oncology Reports · doi:10.3892/or.2015.4394 · Cited by 49
Feng, J.-T., Junhua, C., Li, J., Zhao, R., Zhu, C., Wang, Z., Xie, J., & Tang, W. (2015) · Cell Adhesion & Migration · doi:10.1080/19336918.2015.1112486 · Cited by 48
Jeon, M. J., Kim, W. G., Lim, S., Choi, H.-J., Sim, S., Kim, T. Y., Shong, Y. K., & Kim, W. B. (2015) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2015.10.005 · Cited by 50
Shao, K., Chen, Z. Y., Gautam, S., Deng, N. H., Zhou, Y. L., & Wu, X. (2015) · Glycobiology · doi:10.1093/glycob/cwv089 · Cited by 48
Schaar, A., Sukumaran, P., Sun, Y., Dhasarathy, A., & Singh, B. B. (2016) · Oncotarget · doi:10.18632/oncotarget.12895 · Cited by 48
Martínez-Ramírez, A. S., Díaz‐Muñoz, M., Butanda-Ochoa, A., & Vázquez‐Cuevas, F. G. (2016) · Purinergic Signalling · doi:10.1007/s11302-016-9550-3 · Cited by 48
Cao, Z., Sun, B., Zhao, X., Zhang, Y., Gu, Q., Liang, X., Dong, X., & Zhao, N. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18030500 · Cited by 48
“During EMT, the expression of epithelial markers such as E-cadherin are downregulated and the expression of mesenchymal markers such as Vimentin is upregulated [22,30].”
BackgroundElzamly, S., Badri, N., Padilla, O., Dwivedi, A. K., Alvarado, L. A., Hamilton, M., Diab, N., Rock, C. D., Elfar, A., Teleb, M., et al. (2018) · Breast Cancer Basic and Clinical Research · doi:10.1177/1178223418788074 · Cited by 49
Jaiswal, A., Sabarwal, A., Mishra, J. P. N., & Singh, R. P. (2018) · RSC Advances · doi:10.1039/c8ra05339a · Cited by 48
Unresolved Complexity in the Gene Regulatory Network Underlying EMT
Lavin, D. P., & Tiwari, V. K. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00554 · Cited by 50
O’Brien, S. J., Bishop, C., Hallion, J. C., Fiechter, C. R., Scheurlen, K. M., Paas, M., Burton, J. F., & Galandiuk, S. (2020) · Cancer Biology & Therapy · doi:10.1080/15384047.2020.1794239 · Cited by 49
“Epithelial cells express a number of different cell surface markers, most notably E-cadherin, but also cytokeratins, occludins, and claudins among others.(8,9) These markers are significant factors in cell-cell adhesion and apical-basal cellular polarity.”
BackgroundFang, R., Zhang, G., Guo, Q., Ning, F., Wang, H., Cai, S., & Du, J. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.01.014 · Cited by 45
Wu, K., Zeng, J., Zhou, J., Fan, J., Chen, Y., Wang, Z., Zhang, T., Wang, X., & He, D. (2012) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2012.02.001 · Cited by 47
Jeevan, D. S., Cooper, J., Braun, A., Murali, R., & Jhanwar‐Uniyal, M. (2016) · PubMed · Cited by 46
Könnecke, M., Assmann, M., Pries, R., Böscke, R., Bruchhage, K., Ungefroren, H., Klimek, L., & Wollenberg, B. (2016) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-016-0409-7 · Cited by 47
“Exp. progression (Zeisberg and Neilson 2009).”
Xu, W., Liu, H., Liu, Z., Wang, H., Zhang, F., Wang, H., Zhang, J., Chen, J., Huang, H., Tan, Y., et al. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.01.068 · Cited by 47
Yang, J., Li, M., Chen, X.-O., Lian, Q., Wang, Q., Gao, F., Jin, S., & Zheng, S. (2019) · Respiratory Research · doi:10.1186/s12931-019-1158-z · Cited by 49
Shetty, S. S., Sharma, M., Fonseca, F. P., Jayaram, P., Tanwar, A. S., Kabekkodu, S. P., Satyamoorthy, K., & Radhakrishnan, R. A. (2020) · Japanese Dental Science Review · doi:10.1016/j.jdsr.2020.07.002 · Cited by 49
“Type III EMT exhibits change in the phenotype ith the upregulation of EMT associated genes to promote tissue nvasion and metastasis of cancer cells [10].”
BackgroundKenda-Suster, N., Smrkolj, Š., & Virant-Klun, I. (2017) · Journal of Ovarian Research · doi:10.1186/s13048-017-0306-7 · Cited by 30
“Several molecular mechanisms are involved in this process, like down-regulation of E-cadherin, cytokeratins, zona occludens 1 (ZO-1), claudins, occludin, laminin-1, entactin, mucin 1 (MUC-1), the microRNA 200 family, and acquisition of the transcription factors Snail 1, Snail 2, Twist, Zeb1 and Zeb2/SIP1 as well as N-…”
BackgroundCDKL2 promotes epithelial-mesenchymal transition and breast cancer progression
Li, L., Liu, C., Amato, R. J., Chang, J. T., Du, G., & Li, W. (2014) · Oncotarget · doi:10.18632/oncotarget.2535 · Cited by 45
Zhang, L., Sun, J., Wang, B., Ren, J.-C., Su, W., & Zhang, T. (2015) · Applied Biochemistry and Biotechnology · doi:10.1007/s12010-015-1505-6 · Cited by 46
“The EMT process will result in weakened adhesion ability and enhanced motility [25].”
BackgroundDLG5 in Cell Polarity Maintenance and Cancer Development
Liu, J., Li, J., Ren, Y. T., & Liu, P. (2014) · International Journal of Biological Sciences · doi:10.7150/ijbs.8888 · Cited by 46
“ZO1, located on the plasma membrane surface at sites of the cell-cell junction [29], is a well-known organizer for tight junction and notable epithelial marker [30].”
BackgroundTranscriptional Networks in Epithelial-Mesenchymal Transition
Venkov, C. D., Plieth, D., Ni, T. T., Karmaker, A., Bian, A., George, A. L., & Neilson, E. G. (2011) · PLoS ONE · doi:10.1371/journal.pone.0025354 · Cited by 47
“shared with control fibroblasts, which may reflect the unique transcriptional patterns of parental cells [1] or the axial variability in fibroblast subpopulations [63].”
BackgroundMethodSelf-citationBoström, A.-K., Möller, C., Nilsson, E., Elfving, P., Axelson, H., & Johansson, M. (2011) · Human Pathology · doi:10.1016/j.humpath.2011.06.019 · Cited by 46
ZNF281/ZBP-99: a new player in epithelial–mesenchymal transition, stemness, and cancer
Hahn, S., & Hermeking, H. (2014) · Journal of Molecular Medicine · doi:10.1007/s00109-014-1160-3 · Cited by 47
“mal markers [31, 37].”
Xu, H., Zaidi, M., Struve, J. A., Jones, D. W., Krolikowski, J. G., Nandedkar, S. D., Lohr, N. L., Gadicherla, A. K., Pagel, P. S., Csuka, M. E., et al. (2010) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00123.2010 · Cited by 47
Zheng, L., Fu, Y., Zhuang, L., Gai, R., Ma, J., Lou, J.-S., Zhu, H., He, Q., & Yang, B. Y. (2014) · International Journal of Cancer · doi:10.1002/ijc.28810 · Cited by 46
“4b).(23) As the most important marker for EMT, Ecadherin has been reported to be responsible for the susceptibility of cancer cells to several anticancer drugs.”
BackgroundCarduner, L., Leroy‐Dudal, J., Picot, C. R., Gallet, O., Carreiras, F., & Kellouche, S. (2014) · Clinical & Experimental Metastasis · doi:10.1007/s10585-014-9658-1 · Cited by 46
SNAIL transcription factor increases the motility and invasive capacity of prostate cancer cells
Osorio, L. A., FARFÁN, N. M., Castellón, E. A., & Contreras, H. R. (2015) · Molecular Medicine Reports · doi:10.3892/mmr.2015.4585 · Cited by 46
“In addition, cells, which initiate EMT also increase their synthesis of cytoskeletal proteins, including vimentin (24).”
BackgroundSohal, S. S. (2016) · Respiratory Research · doi:10.1186/s12931-016-0337-4 · Cited by 46
Hu, Z., Yang, A., Su, G., Zhao, Y., Wang, Y., Chai, X., & Tu, P. (2016) · Scientific Reports · doi:10.1038/srep31298 · Cited by 46
Harner-Foreman, N., Vadakekolathu, J. N., Laversin, S. A., Mathieu, M. G., Reeder, S., Pockley, A. G., Rees, R. C., & Boocock, D. J. (2017) · Scientific Reports · doi:10.1038/srep40633 · Cited by 46
Cysteine cathepsins B and X promote epithelial-mesenchymal transition of tumor cells
Mitrović, A., Fonović, U. P., & Kos, J. (2017) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2017.04.003 · Cited by 45
Oral cancer stem cells - properties and consequences
Rodini, C. O., Lopes, N. M., Lara, V. S., & Mackenzie, I. C. (2017) · Journal of Applied Oral Science · doi:10.1590/1678-7757-2016-0665 · Cited by 46
Sharma, S., Goswami, R., & Rahaman, S. O. (2018) · Cellular and Molecular Bioengineering · doi:10.1007/s12195-018-00565-w · Cited by 46
DNA methylation is associated with transcription of Snail and Slug genes
Chen, Y., Wang, K., Qian, C.-N., & Leach, R. E. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.12.034 · Cited by 46
“Defective EMTs or METs are often associated with failures in embryonic development and diseases [3].”
BackgroundKim, S., Oh, S. J., Lee, J., Han, J., Jeon, M., Jung, T., Lee, S. K., Bae, S. Y., Kim, J., Gil, W. H., et al. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000356591 · Cited by 45
Rodrigues‐Díez, R., Lavoz, C., Carvajal, G., Rayego‐Mateos, S., Rodrigues-Díez, R. R., Ortíz, A., Egido, J., Mezzano, S. A., & Ruiz‐Ortega, M. (2013) · Nephron Experimental Nephrology · doi:10.1159/000346575 · Cited by 45
Yang, Z., Hai, B., Qin, L., Ti, X., Shangguan, L., Zhao, Y., Wiggins, L. L., Liu, Y., Feng, J. Q., Chang, J. Y., et al. (2013) · Molecular and Cellular Biology · doi:10.1128/mcb.00456-13 · Cited by 45
“Taken together, we detected all 5 types of markers for EMT (34) in AKO cells, including cell surface proteins (downregulation of E-cad and upregulation of N-cad), cytoskeletal markers (upregulation of Vim and relocation of -catenin), extracellular matrix (ECM) proteins (upregulation of Col1, Bsp, MMP2 and Postn), tran…”
BackgroundFang-Nan, S., Duan, M., Liu, L., Wang, Z., Shi, J.-Y., Yang, L., Zhou, J., Fan, J., Gao, Q., & Wang, X. (2014) · PLoS ONE · doi:10.1371/journal.pone.0108507 · Cited by 45
“, vimentin and N-cadherin) [5,9].”
Metadata
- Authors
- Zeisberg, M., & Neilson, E. G.
- Affiliations
- Beth Israel Deaconess Medical Center (US)
- Vanderbilt University (US)
- Venue
- Journal of Clinical Investigation
- Published
- 2009-06-01
- Volume
- 119
- Issue
- 6
- Pages
- 1429-1437
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC2689132
- OpenAlex
- W1996118868
- Cited by
- 2,299
- References
- 124
- Citations by year
- 2026: 50 · 2025: 79 · 2024: 127 · 2023: 113 · 2022: 146 · 2021: 148 · 2020: 180 · 2019: 163 · 2018: 170 · 2017: 189 · 2016: 153 · 2015: 162 · 2014: 162 · 2013: 149 · 2012: 109
- FWCI
- 8.93
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (R03DK081687, R01DK046282, DK46282, K08DK074558, DK-081687, DK074558)
- Topics
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Health Sciences › Medicine › Immunology and Allergy › Cell Adhesion Molecules Research
- Keywords
- epithelial-mesenchymal transition, cellular plasticity, epithelial cells, endothelial cells, cell motility
- MeSH terms
- Animals, Cell Differentiation, Epithelial Cells, Fibroblasts, Humans, Neoplasms, Biomarkers, Mesenchymal Stem Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review